| Title | A multicenter, open-label, phase I clinical trial to evaluate the safety, tolerability, and pharmacokinetics of JMT-101 in patients (pts) with advanced colorectal cancer (ACC). |
| Authors | Li, Jian Shen, Lin Gong, Jifang Peng, Zhi Liu, Dan Qi, Changsong Yuan, Jiajia Hu, Rong Yang, Xiugao Li, Tao Fu, Dongxue Yang, Ruirui Feng, Li Zhang, Peng Chen, Xin Yuan, Jing Liu, Yuanyuan Wu, Zhufeng Cao, Ye Zhong, Shulin |
| Affiliation | Peking Univ, Canc Hosp & Inst, Dept Gastrointestinal Oncol, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing, Peoples R China Beijing Canc Hosp, Gastrointestinal Med Oncol, Beijing, Peoples R China Peking Univ, Canc Hosp & Inst, Minist Educ Beijing, Dept Gastrointestinal Oncol,Key Lab Carcinogenesi, Beijing, Peoples R China CSPC ZhongQi Pharmaceut Technol Shijiazhuang Co L, Dept Med, Clin Dev Div, Shanghai, Peoples R China Shanghai JMT Bio Technol Co Ltd, Clin Dev Div, Dept Med, Shanghai, Peoples R China CSPC ZhongQi Pharmaceut Technol Shijiazhuang Co L, Dept Clin Operat, Clin Dev Div, Beijing, Peoples R China Shanghai JMT Bio Technol Co Ltd, Clin Dev Div, Dept Clin Operat, Shanghai, Peoples R China CSPC ZhongQi Pharmaceut Technol Shijiazhuang Co L, Clin Dev Div, Data Sci & Biostat, Shanghai, Peoples R China CSPC ZhongQi Pharmaceut Technol Shijiazhuang Co L, Clin Dev Div, Data Sci & Biostat, Wuhan, Peoples R China CSPC ZhongQi Pharmaceut Technol Shijiazhuang Co L, Data Sci & Biostat, Clin Dev Div, Shijiazhuang, Hebei, Peoples R China CSPC ZhongQi Pharmaceut Technol Shijiazhuang Co L, Clin Dev Div, Dept Pharmacovigilance, Beijing, Peoples R China CSPC ZhongQi Pharmaceut Technol Shijiazhuang Co L, Dept Translat Med, Clin Dev Div, Shanghai, Peoples R China |
| Issue Date | 20-May-2020 |
| Publisher | JOURNAL OF CLINICAL ONCOLOGY |
| URI | http://hdl.handle.net/20.500.11897/604228 |
| ISSN | 0732-183X |
| Indexed | CPCI-S(ISTP) SCI(E) |
| Appears in Collections: | 北京肿瘤医院 |
